Bioactivity:

Eribulin mesylate (E7389 mesylate) inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules.�Eribulin mesylate (E7389 mesylate) is a microtubule targeting agent that is used in the treatment of metastatic breast cancer.

CAS nr:

441045-17-6

Purity:

98%

Molecular Weight:

826

SMILES:

[H][C@@]12O[C@]3(CCC4CC(C[C@H]5[C@@H](O[C@@H]([C@@H]5OC)C[C@@H](CN)O)C[C@H]6O[C@@H](CC[C@@H]7O[C@@H](CC[C@@]89C[C@H]([C@@H]2O9)O[C@H]1[C@H]([C@]3(O4)[H])O8)CC7=C)C[C@H](C6=C)C)=O)[H].CS(=O)(O)=O

Formula:

C41H63NO14S

Pathway:

Cytoskeletal Signaling,Others,Apoptosis

Target:

Microtubule Associated,Others,Apoptosis